Drugs Information Online
Drugs and diseases reference index

Drugs and diseases reference index

Drugs A-Z List

Diseases & Conditions A-Z List

Herbs & Supplements

Medical Dictionary

Full Article

Popular Drugs

Popular Diseases & Conditions

Drugs reference index «Mafenide Acetate»

Mafenide Acetate
Mafenide Acetate

Mafenide Acetate

Pronunciation: (MAF-en-ide AS-e-tate)Class: Topical anti-infective

Trade Names:Sulfamylon- Powder for solution, topical 5%- Cream, topical 85 mg per gram


Mechanism of action is unknown; however, it is different from sulfonamides.



Topical mafenide is delivered to burned tissue over a 4-h period following application. Peak concentrations of the cream and solution formulations in burned skin occur at 2 and 4 h, respectively. Following application of the cream, plasma C max occurs in 2 h with levels ranging from 26 to 197 mcg/mL.


Once absorbed, mafenide is rapidly converted to an inactive metabolite.


The metabolite is eliminated through the kidneys. Parent drug and the metabolite blood levels decrease to pretreatment levels within 24 h after application.

Indications and Usage


Use as adjunctive treatment of second- and third-degree burns.


Use as an adjunctive topical antimicrobial agent to control bacterial infections when used under moist dressings over meshed autografts or excised burn wounds.


Standard considerations. It is not known if there is cross-sensitivity to other sulfonamides.

Dosage and Administration

Adults and Children 3 mo of age and older



Apply 1 to 2 times daily, to a thickness of about 1/ 16 inch.


Cover grafted area with 1 layer of fine mesh. Cut an 8-ply burn dressing to the size of the graft and wet with mafenide acetate 5% solution using an irrigation syringe and/or irrigation tubing until leaking is noticeable. If irrigation tubing is not used, the gauze dressing may be moistened every 6 to 8 h as needed to keep it wet. Safety and efficacy have not been established for treatment longer than 5 days for an individual graft procedure.

General Advice

  • Cream
  • Apply with a sterile gloved hand.
  • Keep burned area covered at all times, reapplying to any area from which the cream has been removed.
  • Dressings usually are not required. However, if a dressing is necessary, apply only a thin layer of dressing.
  • Patient should be bathed daily to aid in debridement.
  • Continue treatment until healing is progressing well or until the burn site is ready for grafting.
  • Solution
  • If wetted with irrigation tubing, place the tubing over the burn dressing in contact with the wound and cover with a second piece of 8-ply dressing.
  • Secure irrigation dressing with a bolster dressing.
  • Keep gauze wet.
  • Wound dressings may be left undisturbed, except for the irrigations, for up to 5 days. Additional soaks may be initiated until graft take is complete.
  • Maceration of the skin may result from wet dressings applied for intervals as short as 24 h.



Store undiluted packets at 59° to 86°F. Store prepared solution at 59° to 86°F for up to 28 days in an unopened container. Once container is opened, any unused solution must be discarded within 48 h.


Avoid temperatures above 104°F. Protect from light.

Drug Interactions

None well documented.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Rash (5%); itching (3%); blisters; erythema; facial edema; hives; swelling.


Bone marrow depression (rare); eosinophilia; fatal hemolytic anemia.


Burning sensation; pain.


Decreased pCO 2 ; increased serum chloride; metabolic acidosis.


Hyperventilation; tachypnea.


Acute porphyria (rare).



Monitor the site for bacterial growth during interruption of treatment (eg, acidosis, allergic reaction). Monitor acid-base balance, especially in patients with extensive second-degree or partial-thickness burns, and in those patients with pulmonary or renal dysfunction.


Category C .




Safety and efficacy not established in children younger than 3 mo of age.


Safety and efficacy not established.


If allergic reactions occur, consider discontinuing treatment.

Renal Function

Use with caution in patients with acute renal impairment.

Sulfite Sensitivity

Mafenide cream contains sodium metabisulfite, which may cause allergic-type reactions, including anaphylactic symptoms and life-threatening or severe asthmatic episodes in susceptible people.


May occur. If acidosis becomes difficult to control, discontinuing the soaks for 24 to 48 h may aid in restoring acid-base balance.

Fungal colonization

May occur concurrently with reduction of bacterial growth in the burn wound. Systemic fungal infection through the burn wound is rare.

Hemolytic anemia

Fatal hemolytic anemia with DIC, presumably related to G-6-PD deficiency, has been reported.


Masked hyperventilation with resulting respiratory alkalosis has occurred.

Metabolic acidosis

May occur as a result of carbonic anhydrase inhibition, usually compensated by hyperventilation. The carbonic anhydrase inhibition may be exaggerated in patients with renal function impairment.



Data are lacking.

Patient Information

  • Advise patients to notify their health care provider if condition worsens, if irritation occurs, or if hyperventilation occurs.
  • Advise patients using mafenide cream to bathe burned area daily; a whirlpool bath is particularly helpful.

Copyright © 2009 Wolters Kluwer Health.

  • mafenide topical Concise Consumer Information (Cerner Multum)
  • Sulfamylon Prescribing Information (FDA)
  • Sulfamylon Topical Advanced Consumer (Micromedex) - Includes Dosage Information
  • Sulfamylon Cream MedFacts Consumer Leaflet (Wolters Kluwer)

Comment «Mafenide Acetate»